Latest Articles

• 

  The future of US aid

  The future of US aid

  Opinion: The new US development agency could be a game-changer for health innovation

  1 Nov 2019

  As the leaders of the new U.S. International Development Finance Corporation start laying the groundwork for an investment strategy, they should look toward health as a key priority, writes PATH CEO Steve Davis.

• 

  Sponsored by Path, Devex World Innovation Partner

  Sponsored by Path, Devex World Innovation Partner

  'The Innovation Effect': 5 reasons it matters

  30 Jun 2016

  How will we break the cycle of poverty, empower women and girls, and give families the means to prosper? Innovation.

• 

  #FutureINGO

  #FutureINGO

  Reimagining the INGO business model

  28 May 2015

  For several decades, project-focused funding in global health and development has shaped an INGO operating model that often fails to achieve results in the most efficient and scalable manner. In this guest column, Steve Davis, PATH's president and CEO writes that a shift is necessary and possible, despite the challenges.

• #MDGMOMENTUM

  Innovation knows no borders: Delivering on the health MDGs

  30 Jul 2014

  It’s time to radically change the course of human development in global health. How? By encouraging local innovations that have worldwide impact and embracing technology, PATH President and CEO Steve Davis writes in an opinion for the MDG500 campaign.

• Best Buys in Global Health

  Let’s go the distance: Investing in partnerships for a healthier future

  19 Mar 2014

  Here’s why we’re joining forces to push sound investments in global health. A commentary by three global development leaders — PSI's Karl Hofmann , PATH's Steve Davis and Devex's Raj Kumar — inspired by a survey of global health professionals.

• See all articles by Steve Davis